Grunenthal (Branded Product Portfolio) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Grunenthal (Branded Product Portfolio) General Information
Description
14 own and licensed brands in Eastern Europe and the Middle East. The products include Tramal, Zaldiar, Transtec and Palexia currently sold in the contract area in Russia, Bosnia, Latvia, Estonia, Saudi Arabia, Kuwait, Lebanon, Jordan, the United Arab Emirates, Egypt, Yemen, Oman, Bahrain and Qatar.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
- Zieglerstraße 6
- 52078 Aachen
- Germany
Grunenthal (Branded Product Portfolio) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Grunenthal (Branded Product Portfolio) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|